Results 171 to 180 of about 1,409,842 (340)

Early detection of oral cancers [PDF]

CA: A Cancer Journal for Clinicians, 1996
openaire   +2 more sources

Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program

, 2015
A. Blythe Ryerson, Jacqueline W. Miller, Christie R. Eheman   +2 more
openalex   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Signatures Beyond Oncogenic Mutations in Cell-Free DNA Sequencing for Non-Invasive, Early Detection of Cancer. [PDF]

Front Genet, 2021
De S.
europepmc   +1 more source

Mass Screening for Early Detection of Breast Cancer Conducted in Miyagi Prefecture.

, 1996
Michio Kimura, Kohichi Yoshida, Akio Ohuchi, Noriaki Ohuchi, Kenichi Shiiba, Seiki Matsuno, Tetsutaroh Takeda   +6 more
openalex   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples. [PDF]

Sci Rep, 2021
Lanza E, Di Rocco M, Schwartz S, Caprini D, Milanetti E, Ferrarese G, Lonardo MT, Pannone L, Ruocco G, Martinelli S, Folli V.   +10 more
europepmc   +1 more source

The early detection of oral cancer using oral cytology (Review Article)

, 2013
Hiroaki Ishibashi, Katsumi Hideshima, Joji Sekine   +2 more
openalex   +2 more sources

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

Molecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui, Matthew A. Cottam, Muhammad Bilal Mirza, Keeli B. Lewis, Kristen K. Ciombor, Mary Kay Washington, Kamran Idrees   +6 more
wiley   +1 more source

Serial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients: A Single-Centre Observational Study. [PDF]

J Clin Med, 2023
Moya A, Buytaert D, Beles M, Paolisso P, Duchenne J, Huygh G, Langmans C, Roelstraete A, Verstreken S, Goethals M, Dierckx R, Bartunek J, Penicka M, Van Camp G, Heggermont WA, Vanderheyden M.   +15 more
europepmc   +1 more source